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Abstract During endochondral ossiWcation hypertro-
phic chondrocytes in the growth plate of fetal long
bones, ribs and vertebrae play a key role in preparing
growth plate cartilage for replacement by bone. In
order to establish a reporter gene mouse to facilitate
functional analysis of genes expressed in hypertrophic
chondrocytes in this process, Col10a1- BAC reporter
gene mouse lines were established expressing LacZ
speciWcally in hypertrophic cartilage under the control
of the complete Col10a1 gene. For this purpose, a bac-
terial artiWcial chromosome (BAC RP23-192A7) con-
taining the entire murine Col10a1 gene together with
200 kb Xanking sequences was modiWed by inserting a
LacZ-Neo cassette into the second exon of Col10a1 by
homologous recombination in E. coli. Transgenic mice
containing between one and seven transgene copies
were generated by injection of the puriWed BAC-
Col10a1- lLacZ DNA. X-gal staining of newborns and
embryos revealed strong and robust LacZ activity
exclusively in hypertrophic cartilage of the fetal and
neonatal skeleton of the transgenic oVspring. This indi-
cates that expression of the reporter gene in its proper
genomic context in the BAC Col10a1 environment is
independent of the integration site and reXects authen-
tic Col10a1 expression in vivo. The Col10a1 speciWc
BAC recombination vector described here will enable
the speciWc analysis of eVector gene functions in hyper-
trophic cartilage during skeletal development, endo-
chondral ossiWcation, and fracture callus healing.
Keywords Collagen X · Hypertrophic cartilage · 
BAC · Transgenic mouse · Homologous recombination
Introduction
Cartilage–bone transition by endochondral ossiWcation
is a highly complex process which determines not only
longitudinal growth of long bones, ribs and vertebrae,
but also plays a critical role in bone fracture callus
healing, osteophyte formation and cartilage tissue
engineering. Decisive steps in this process are prolifer-
ation, maturation and hypertrophy of chondrocytes in
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the growth plate which play a key role in mineraliza-
tion, apoptosis and induction of resorption of hypertro-
phic cartilage by invading bone marrow. These events
are regulated by synergistic action of several signaling
pathways and transcriptions factors controlled by a
multitude of growth factors and hormones.
A major signaling system regulating chondrocyte
proliferation and maturation is controlled by PTHrP,
which is induced by Indian hedgehog, stimulates chon-
drocyte proliferation and delays maturation through
the PTHrP receptor PTHR1 [for reviews see (Kronen-
berg et al. 1998; Vortkamp 2000)]. Also FGF factors
stimulate proliferation and block maturation through
FGF receptor 3, but their action in the growth plate is
more complex with respect to the diVerential distribu-
tion of diVerent FGFs and FGF receptors in the vari-
ous zones of the growth plate (Ornitz and Marie 2002).
The role of BMPs during chondrocyte maturation
and hypertrophy is somewhat controversially discussed:
several studies show that BMP factors such as BMP-6
and BMP-7 stimulate hypertrophic diVerentiation of
chondrocytes and promote collagen X expression, thus
preparing growth plate cartilage for replacement by
endochondral bone (Enomoto-Iwamoto et al. 1998;
Volk et al. 1998; Grimsrud et al. 2001). On the other
hand, it was reported that BMP-2 and BMP-4 overex-
pression in developing chick limbs caused delayed
hypertrophy of chondrocytes (Duprez et al. 1996).
The fourth family regulating chondrocyte maturation
are Wnt factors and the Wnt/-catenin signaling system
(Dong et al. 2005), also acting in diverse directions. For
example, Wnt 7a inhibits chondrogenesis and Wnt 5a
impairs chondrocyte hypertrophy and type X collagen
(Col10a1) expression in vitro (Daumer et al. 2004), but
activation of the canonical -catenin pathway by Wnt 8c
and Wnt 9a induces chondrocytes maturation, hypertro-
phy and calciWcation, associated with upregulation of
Col10a1 expression (Enomoto-Iwamoto et al. 2002;
Dong et al. 2005, 2006; Hu et al. 2005).
Recently increasing evidence points to complex cros-
stalks between these signaling pathways. For example,
there is experimental evidence for a coordination
between Indian hedgehog and BMP signaling in chon-
drocyte proliferation (Minina et al. 2002). Targets of the
signaling pathways in the growth plate are transcription
factors such as Sox9 responsible for chondrogenic diVer-
entiation (Ng et al. 1997; Lefebvre and de Crombrugghe
1998) and cbfa1/runx2 inducing osteogenic diVerentia-
tion (Karsenty et al. 1999; Ducy 2000) as well as chon-
drocyte maturation and Col10a1 expression (Kim et al.
1999; Enomoto et al. 2000; Zheng et al. 2003).
There is ample evidence in the literature that factors
regulating chondrocyte maturation and hypertrophy
may be also directly involved in the regulation of
Col10a1 gene expression, e.g. PTHrP (Iwamoto et al.
1994; Ionescu et al. 2001; Riemer et al. 2002; Gebhard
et al.  2004), Runx2 (Enomoto-Iwamoto et al. 2001;
Leboy et al. 2001; Zheng et al. 2003), BMP2 (Volk
et al.  1998; Grimsrud et al. 2001), or c-fos (Thomas
et al. 2000; Riemer et al. 2002). Thus, in order to eluci-
date the exact role of the various signaling systems
and involved factors regulating endochondral ossiWca-
tion, it would be useful to generate a reporter gene
mouse in which the expression of LacZ is under the
control of the complete Col10a1 gene regulatory
sequences.
Previously we have reported on the generation of
transgenic mouse lines in which LacZ expression is
under the control of the 4.6 kb promoter of Col10a1
which includes a strong enhancer element (Gebhard
et al.  2004) and runx2 binding sites (Zheng et al.
2003). We have shown that this promoter is suYcient
to drive speciWc expression of LacZ reporter genes in
hypertrophic chondrocytes of growth plate cartilage
of long bones, ribs, vertebrae and sternal cartilage
(Gebhard et al. 2004). Reporter gene expression was
restricted to hypertrophic cartilage, but not all hyper-
trophic chondrocytes in the growth plate of 18.5-day
embryos were found to be lacZ positive, and only
weak lacZ expression was observed at early embry-
onic stages before day E17. Furthermore, not all
transgenic founders containing the LacZ transgene
showed lacZ activity in the growth plates, suggesting
a high level of sensitivity to interfering activities of
the genomic context of insertion or additional regula-
tory elements in the Col10a1 gene further upstream
of the enhancer or downstream of the coding
sequences.
Here we report on the construction of a BAC
reporter mouse expressing lacZ under the control of
the Col10a1 gene. A LacZ-Neo cassette was inserted
into the second exon of Col10a1 within the context of a
215 kb BAC using a phage-based homologous recom-
bination system in E. coli (Yu et al. 2000; Lee et al.
2001). Transgenic mouse lines established with this
modiWed BAC show speciWc LacZlacZ expression at
high levels in hypertrophic zones of long bones, ribs,
vertebrae, mandibles and sterna of transgenic mouse
lines. No signiWcant unspeciWc expression was detected
in other chondrogenic or non-chondrogenic tissues
except some transient, probably unspeciWc X-gal reac-
tion in the prenatal epidermis and hair papillae.
The robust and speciWc expression of Col10a1-based
BAC recombineering vectors in transgenic mice opens
new and unique possibilities to study the role of growth
factors and transcription factors in chondrocyte hyper-Histochem Cell Biol (2007) 127:183–194 185
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trophy and endochondral ossiWcation, and to deWne
further cis-acting regions in the Col10a1 gene.
Materials and methods
BAC clones
Murine Col10a1 containing BAC clones were selected
from the UCSC Bioinformatic databases (http://
www.genome.ucsc.edu/) (Kent et al. 2002); clone
RP23-192A7 contained 211 kb of genomic DNA Xank-
ing the Col10a1 gene derived from the L129 mouse
strain. RP23-192A7 (cloned in the pBACe3.6 vector)
was obtained from the BACPAC Resources Center at
Children’s Hospital Oakland Research Institute,
(CHORI). The presence of the full-length Col10a1
gene was veriWed by PCR ampliWcation using both
primers for detecting the enhancer at ¡4.6 kb (Enm-
col10a1-3: ATT CTC GAG CTT TGG GAA GCA
TGG TG ; Enmcol10a1-5: CAA GAA ATC TTT
GGG AAA TGA ATG AAT G ) (Gebhard et al.
2004) , and for a region 2036 bp downstream of the
poly A site of the Col10a1 gene (mcol10a1-psg-5: TCT
ACC AGG AGG CCT CTC TTC AAT GTT AC;
mcol10a1-psg-3:
GGG AAT TCT TAC CTT AAA GTA GAT ACA
TG (amplicon size 222 bp).
Construction of targeting vector 
placH+Col10a1-lacZ-frt-neo-frt
The 5 recombination site was generated by PCR
ampliWcation of a 129 bp fragment mapping to the
113 bp 3-end of intron 1 and 16 bp of the 5-UTR
encoded in exon 2 by using BAC RP23-192A7 as tem-
plate (see Fig. 1). Terminal SalI and NcoI restriction
sites were added by using primers Col10a1-5SalI (5-
ACG CGT CGA CGA TAT CTC AGT CAT TTA
AAA AAC CAT GA) and Col10a1-5NcoI (5-CAT
GCC ATG GAT TTT CAG ATA GAT TCT GAA
AAG CAG A. The product was digested with SalI and
NcoI and cloned into the multiple cloning site 2 of plas-
mid placH (Zhou et al. 1995) kindly provided by Dr. V.
Lefebvre, Cleveland) containing the lacZ gene and the
3-end of the murine protamine 1 gene with an intron
and poly A signal resulting in clone placH+
5COL10a1. Use of the NcoI site linked the lacZ reading
frame to the start ATG of Col10a1.
The 3 recombination site was generated by overlap-
ping primers corresponding to a 57 bp sequence of
exon 2. Additional HindIII sites were introduced at
both ends as well as a XhoI site at the 3-end. The frt-
neo-frt cassette of the pICGN21 vector (Yu et al. 2000;
Lee et al. 2001); kindly provided by Dr. Copeland) har-
boring the neomycin phosphotransferase gene under
the SV40 promoter, an HSV thymidine kinase and a
Fig. 1 Generation of the BAC-Col10a1-lacZ-neo DNA for the
transgenic expression of the lacZ reporter gene in hypertrophic
cartilage. a Genomic structure of the murine Col10a1 gene, with
exons (gray boxes) and introns. The sequences used for genera-
tion of the 5 and 3 homologous regions in exon 2 and intron 1
are shown in black. b The targeting vector placH- Col10a1-lacZ-
frt-neo-frt contains Col10a1 derived 5 and 3 homology domains
Xanking a lacZ-frt-neo-frt cassette for homologous recombina-
tion in E. coli. The lacZ coding sequence was fused with the start
ATG of the Col10a1 reading frame; shown is only the insert of
the targeting vector, contained in the placH vector. c Partial map
of the BAC-clone Col10a1-lacZ-frt-neo-frt clone after homolo-
gous recombination with the targeting vector placH-Col10a1-
lacZ-frt-neo-frt
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poly A signal was ampliWed by PCR using primer FRT-
Neo5´HindIII (5-AGT CAA GCT TTA ACT GAT
CGC GGC CAG CTT GAA GTT) (pIGCN21
sequence pos. 4664–4689, marked in bold) and the
primer Col10a1-3HindIII (5-TAA AGC TTC TCG
AGT TGT GTC TTG GGG CTA GC AAG TGG
GCC CTT TAT GCC TGT GGG CGT TTG GTA
CCG TTC TAT TCC AGA AGT AGT GAG GAG
GCT TT) and plasmid pICGN21 as template (pICGN2
sequences pos. 6103 to 6123 marked in italics) and
Col10a1 from exon 2 (82 to 138, underlined). The prod-
uct was digested with HindIII and inserted into the
multiple cloning site behind the mP1 gene of
placH+5Col10a1. The resulting plasmid placH+
Col10a1-lacZ-frt-neo-frt was veriWed to be correct by
restriction digestion and sequencing for correct inser-
tion and composition.
Homologous recombination and detection of BAC 
transgene
BAC RP23-192A7 was electroporated into the E. coli
strain EL250 (DH10B[cl857(cro-bioA)<>araC-
PBADXpe]) kindly provided by Dr. Neal G. Copeland,
NCI, Frederick, MD, USA, containing a defective 
prophage which supplies essential functions (exo, bet,
gam) to protect and enhance recombination of linear
DNA (Lee et al. 2001).
The 5.1 kb recombination cassette was excised from
plasmid placH+COL10a1-lacZ-frt-neo-frt by XhoI;
complete linearization with XhoI was important to
avoid ampliWcation of the circular targeting vector in
E. coli.
For homologous recombination 300 ng linear frag-
ment was transformed by electroporation according to
Dower (Dower et al. 1988) in 0.1 ml cuvettes contain-
ing 50 l of ice-cold competent EL250 containing BAC
RP23-192A7, using a Bio-Rad gene pulser set at
1,750 kV, 23 mF with a pulse controller set at 200 .
Electrocompetent bacteria were prepared as described
in (Lee et al. 2001). A 15 min heat shock at 42°C was
used for induction of the homologous recombination
machinery according to (Yu et al. 2000; Lee et al.
2001). Transformed cells were incubated for 1.5 h at
32°C in 1 ml of LB and selected for chloramphenicol-
and kanamycin-resistance. Resulting clones (RP23-
192A7 + lacZ-frt-neo-frt) were screened for homologous
recombination by PCR detecting the 5 recombination
event (amplicon 437 bp) using primers P1 (5-TTT
AGA GCA TTA TTT CAA GGC AGT TTC CA)
and P2 (5-CGG CAC CGC TTC TGG TGC CGG
AAA CCA GGC), and the 3 recombination event
(product 378 bp) using primers P3 (5-ACA GAA
TAA AAC GCA CGG GTG TTG GGC GT) and P4
(5-ATC ATT CCG CTG TAC TAG CTC AAG CCA
ATC). Direct sequencing of BAC DNA was per-
formed with primers P1 and P4.
BAC DNA puriWcation and generation of transgenic 
mice
BAC-Col10a1 - lacZ-neo DNA from clone#11 was
extracted from multiple E. coli EL250-BAC#11 mini-
preps by alkaline lysis (Sambrook et al. 2001), puriWed
by potassium acetate precipitation, washed with etha-
nol and dissolved in Tris-EDTA (TE) buVer. For size
and quality control, aliquots were subjected to pulsed
Weld gel electrophoresis (PFGE) (Fig. 2). For puriWcation,
50 g BAC DNA of clone#11(BAC-Col10a1-LacZ-neo)
were dissolved in TE buVer and concentrated to 500 l
by vacuum centrifugation. The DNA was linearized
overnight with PISceI enzyme (NEBiolabs) cleaving
the unique site in the BACe3.6 vector part. For chro-
matographic puriWcation a 5 ml plastic pipette was
packed with Sepharose CL-4B (Pharmacia) equili-
brated in microinjection buVer (5 mM Tris/HCl, pH
7.4, 0.1 mM EDTA, 5 mM NaCl) (Zeilhofer et al.
2005), the linearized BAC#11-DNA was mixed with
bromophenol blue and chromatographed. Half millili-
ter fractions were collected until the dye reached the
column bottom, and BAC DNA concentration in each
fraction was analyzed by PFGE using serial dilutions of
BAC RP23-192A7 DNA as internal standard. The
BAC DNA concentration of the main fraction was
Fig. 2 Characterization of one of the BAC-Col10a1-LacZ-frt-
neo-frt clones (clone#11). Digestion with PISceI (lane 3), NotI
(lane 4), PmeI (lane 5) and NruI (lane 6) resulted in fragments of
the expected sizes. Sizes are compared with 1 kb marker (lane 1),
1 kb extension (lane 2) and PFG marker (lane 7), and the lengths
are indicated. For microinjection, BAC #11 DNA was linearized
with PISceI, puriWed by gel chromatography on Sepharose CL4B
equilibrated in microinjection buVer and analyzed and quanti-
tated by pulsed Weld gel electrophoresis
1  2   3    4   5   6        7
248 kb
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adjusted to 1.5 ng/l, and NaCl concentration was
increased to 100 mM to stabilize BAC DNA. Fractions
were stored at 4°C until microinjection. Injection into
fertilized oocytes and generation of transgenic mice
was performed by standard techniques using oocytes
from FVB mice and FVB/ FVBxC57BL6 F1 hybrids as
described (Zeilhofer et al. 2005).
Genotyping of transgenic mouse lines
Transgenic founder animals were selected by PCR of
tail biopsies using primers pairs P1/P2 and P3/P4 (see
above) detecting recombination events. Each sample
was standardized by PCR using P1/P4 primer pair
which generates a 538 bp fragment from the wt
Col10a1 allele. Founders derived from injections of F1
hybrids were crossed with C57BL6, whereas founders
derived from FVB oocytes were crossed with FVB
mice. For genotyping of newborn mice and embryos
DNA was extracted from skin or placenta, and trans-
gene DNA was identiWed by PCR as above.
Histological analysis and in situ hybridization
Newborns mice were anesthetized under CO2, dis-
sected and subjected to X-gal staining, followed by
either clearing with KOH Wxation, embedding into par-
aYn or by cryotome sectioning as described (Zhou
et al.  1995). Embryos at 12.5 to 16.5 day were left
undissected and stained with X-gal. ParaYn and frozen
sections were counterstained with eosin.
In situ hybridization for collagen X was performed as
described previously (Aigner et al. 1992), but using a
digoxigenin-labeled mouse Col10a1-speciWc anti-sense
probe derived from the 3-end of the Col10a1 gene
instead of 32P-labeled dCTP. Non-radioactive in situ
hybridization was done as described elsewhere (Schmidl
et al.  2006), using alkaline phosphatase labeled anti-
digoxigenin antibodies and BM purple (Roche) as color
substrate according to the manufacturers protocol.
Determination of transgene copy number 
by Southern hybridization
For quantitative analysis of transgene copy number,
genomic DNA was isolated from skin of newborns or
from placenta of embryos and cleaved with BamHI.
For standardization 5 g wild-type DNA were mixed
with 0.37 ng up to 18.38 ng RP23-192A7 + lacZ-frt-
neo-frt DNA corresponding to 1 up to 50 copies of
recombined BAC per lane. Samples for standardiza-
tion and 5 g of DNA from transgenic founders were
cleaved with BamHI, separated on 1% agarose gels
and blotted onto nylon membranes. Membranes were
hybridized to with a 32P-labeled probe derived for from
the pBACe3.6 vector, prepared by PCR using primers
BAC11-5 (5-TTTAAACGTGGCCAATATGGA)
and BAC11-6 (5-CGCGGATCCTCTCCCTAT). An
8 kb band was detected in transgenic samples and the
intensity was measured in a FLA-3000 phosphoimager
(FujiWlm) using the AIDA program (Advanced Image
Data Analyzer, Raytest ).
Results 
Construction of a placH-Col10a1-lacZ-frt-neo-frt
targeting vector and homologous recombination
The BAC clone RP23-192A7 selected from the
CHORI BAC library RPCI23 contains the mouse
Col10a1 gene (7.2 kb) with 171 kb of upstream and
33 kb of downstream genomic regions. For insertion of
the  lacZ reporter gene into the second exon of the
Col10a1 gene by homologous recombination, a target-
ing vector was constructed containing the lacZ gene
linked to a neomycin resistance cassette Xanked by two
frt sites. The targeting vector was Xanked by a 129 bp
5-terminal homology arm overlapping parts of the 3-
end of intron 1 and 14 bp of exon 2 including the start
ATG for fusion with NcoI. The 3 recombination site
mapped to a 57 bp sequence in the 3 part of exon 2
(Fig. 1b). The vector construct was veriWed by restric-
tion mapping, Southern blotting and sequencing. Initial
attempts using shorter homology regions resulted in
mostly incorrect recombination events.
For homologous recombination, the BAC clone
RP23-192A7 was electroporated into the E. coli strain
EL250, resulting in EL250/RP23-192A7. The Col10a1-
lacZ-frt-neo-frt insert was excised from the targeting
vector with XhoI (Fig. 1) and electroporated into elec-
trocompetent EL250/RP23-192A7. Chloramphenicol-
and kanamycin-resistant BAC-positive clones were
selected and tested by PCR for homologous recombi-
nation by using two primer pairs P1/P2 and P3/P4 (see
Fig. 1 and Materials and Methods) speciWc for the 5-
and 3- recombination sites, respectively. To verify the
integrity of the Col10a1 gene in its genomic context
after homologous recombination, the presence of the
enhancer at 4.6 kb upstream the transcription site and
the 5-end of a pseudogene downstream of the 3 UTR
sequences was veriWed by PCR with speciWc primers
(see Fig. 1 and Materials and Methods) and sequencing
of the BAC DNA. Furthermore, intact BAC ends were
conWrmed by PCR, using primers derived from the
pBACe3.6 vector and the genomic insert.188 Histochem Cell Biol (2007) 127:183–194
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To minimize BAC degradation, DNA was prepared
from BAC-Col10a1-LacZ-Neo clone #11 by alkaline
lysis and ethanol precipitation, avoiding absorption to
minicolumns and shear stress. Control of the BAC DNA
by PFGE conWrmed the expected size of 220 kb (Fig. 2).
Generation of transgenic mice
DNA from BAC-Col10a1-lacZ-neo (clone #11) was
linearized with PISceI at the unique restriction site in
the pBACe3.6 vector sequence, puriWed by molecular
sieve chromatography, and injected into the pronuclei
of fertilized oocytes of FVB mice and FVB/C59Bl F1
hybrids. Both strains were by far superior in litter size
and successful raising oVspring as compared to C57/Bl6
mice. Out of 70 newborn pups, 13 were found harbor-
ing the lacZ gene after PCR analysis of genomic DNA,
using primer pairs P1/P2 and P3/P4 (see Fig. 1). South-
ern blot analysis of genomic DNA (Fig. 3a) as well as
Real- time PCR analysis of genomic DNA using
Col10a1 intron speciWc primers showed that the
founders contained between one and seven transgene
copies (Table 1)
Seven of the 13 independent founder lines were ana-
lyzed so far for LacZ activity by X-gal staining of new-
borns or embryos (all F1 generation). All oVspring
analyzed revealed strong LacZ activity after X-gal
staining which was restricted to the hypertrophic zones
in all growth plates of long bones, ribs, vertebrae,
sternebrae and to hypertrophic cartilage in the skull in
E14.5- and E16.5-day embryos and newborns (see
Figs. 4, 5, 6). The X-gal staining pattern was identical in
all seven lines investigated, while staining intensity
varied in relation to the BAC transgene copy number
(Fig. 3b). Under identical staining conditions, X-gal
staining was strongest in founder #1520 (seven trans-
gene copies), followed by #800 (Wve copies) and #986
(three copies) (Fig. 3b).
SpeciWc expression of the BAC-Col10a1-LacZ-neo 
transgene in hypertrophic cartilage
Various stages of embryonic development were ana-
lyzed for expression of the BAC-Col10a1-lacZ-neo
Fig. 3 a Analysis of BAC transgene copy numbers in 13 trans-
genic founders by Southern hybridization. Genomic DNA was
isolated from skin of newborns, cleaved with BamHI, separated
on 1% agarose gels and blotted onto nylon membranes. Mem-
branes were hybridized with a 586 bp 32P-labeled probe derived
from the pBACe3.6 vector which recognizes an 8 kb band in
transgenic samples. Band intensities were quantitated in a phos-
phoimager. Copy numbers of transgene BAC DNA (Table 1)
were calculated on the basis of a standard curve established with
serial dilutions of BAC DNA starting from 50 copies down to 1
copy of BAC RP23-.192A7, diluted in 5 g of wt DNA. b Com-
parison of LacZ activity in the scapulae of three diVerent BAC
transgenic lines harboring diVerent BAC copy numbers shows
some correlation between staining intensity and BAC copy num-
ber. All specimen were from new born animals and stained under
identical conditions with X-gal for 18 h
copy number of BAC
0     1      5   10   2 5  50
founder no
800
986
1534
1520
1524
1527
1533
1504
1508
1510
1515
1516
1501 A
#968
3 copies 5  copies 7 copies
#1520 #800
B
Table 1 BAC transgene copy number in 13 founders, deter-
mined by Southern hybridization (see Materials and methods)
ND not determined
Founder # Strain sex -gal 
activity
BAC 
copy no.
800 FVB, m + 5
986 FVB, f + 3
1501 FVB, f + 1
1504 FVB, m + 3
1508 F1, f ND 2
1510 F1, m ND 1
1515 F1, f ND 4
1516 F1, f + 6
1520 F1, m + 7
1524 F1, f ND 2
1527 F1, m ND 1
1533 FVB, m ND 1
1534 FVB, m + 4Histochem Cell Biol (2007) 127:183–194 189
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transgene by X-gal staining. In E14.5-day embryos,
strong LacZ activity was seen in all ribs, the hypertro-
phic zones of scapula, humerus, radius and ulna in the
forearm and femur, tibia and Wbula of the hindleg, as
well as in mandibles and cervical vertebrae (Fig. 4a).
At day 16.5, the extent of X-gal staining expanded in
the diaphyseal region of scapula, humerus and in the
ribs, corresponding to the expansion of the hypertro-
phic zones at this embryonic stage. (Fig. 4b, e) Section-
ing of X-gal-stained embryos revealed that the lacZ
transgene expression in the skeleton occurred exclu-
sively in the hypertrophic zone of growth plates and
ribs (see Figs. 5, 6), correlating with collagen X expres-
sion as seen by in situ hybridization (Fig. 6g, h).
At embryonic stages E12.5 to 16.5 X-gal staining
also occurred in some regions of the epidermis
(Fig. 4b, arrow, Fig. 4c, d), mainly in the papillae of
the forehead in the snout (Fig. 4c), and in the skin of
the tail, hindlegs, forelegs, and shoulder It was
restricted to the basal layer of keratinocytes (Fig. 4d)
and seen at E12.5 day before the Wrst appearance of
hypertrophic chondrocytes in cartilage, but was not
detected after birth. It seemed unspeciWc as no 1(X)
mRNA signals were seen in the epidermis or hair
papillae at any stage of development by in situ hybrid-
ization (N. Adam and K. von der Mark, unpublished
data).
Transgenic newborn F1 oVspring of all seven
founders analyzed so far revealed an even and strong
LacZ activity in all growth plates of long bones
(Figs. 4e, 5a, b), ribs (Figs. 4e, 5g), vertebrae (Figs. 4e,
5f, h), and sternebrae (Figs. 4e, 5i). In the skull, LacZ
activity was seen in mandibular condyles, in hyoid car-
tilage, heads of malleus and ramus, ectooccipital and
basisphenoid bone anlagen, cervical vertebrae and
other ossifying cartilage anlagen (Fig. 5e). The high
intensity of X-gal staining allowed the visualization of
discrete zones of Col10a1 expression in hypertrophic
cartilage, for example the inner and outer aspects of
the thoracal and cervical vertebrae (Fig. 5f, h).
Fig. 4 Detection of lacZ expression in BAC-Col10a1-lacZ-Neo
transgenic embryos by X-gal staining at E14.5 (a), E16.5 (b) and
P1 (e) of the F1 generation of founder lines #1534 (a), #1504 (b),
and #1520 (c). X-gal staining reveals strongest expression in chon-
drocytes in the hypertrophic zones of the scapula (s), humerus
(h), femur (f), clavicula (cl) and all other long bones, furthermore
in the hypertrophic zone of the ribs and in cervical vertebrae (c1,
c2), (p pelvic bone). c, d In E16.5 embryos some X-gal staining
was also seen in the epidermis of the tail (b arrow) and in hair
papillae of the forehead and snout, and at nostrils (n). This
expression is restricted to some basal keratinocytes in the epider-
mis, here shown in a section of the snout (d). It disappears after
birth and may be a result of unspeciWc -gal activity. No LacZ
activity was detected in non-hypertrophic chondrocytes or in non-
chondrogenic tissues.190 Histochem Cell Biol (2007) 127:183–194
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Analysis of the X-gal staining pattern in paraYn and
frozen sections of transgenic embryos and newborn
mice conWrmed that the LacZ activity was restricted to
hypertrophic chondrocytes (Fig. 6), shown here for the
humerus (a), radius (b), sternum (c), atlas (d), and ribs
(e, f). The X-gal staining pattern correlated well with
the expression pattern of 1(X) collagen mRNA seen
by in situ hybridization analysis of a similar section
(Fig. 6g, h). Neither non-hypertrophic chondrocytes
nor any non-chondrocytic cell types revealed detect-
able levels of LacZ-activity in newborn transgenic ani-
mals. After prolonged staining, a non-speciWc reaction
appeared in osteoclasts of long bones in transgenic and
wildtype animals owing to endogenous galactosidase
activity. Regardless of the transgene copy number, the
LacZ activity in the oVspring of all founders was seen
persistently in all hypertrophic chondrocytes of the
developing skeleton.
Discussion
In a previous report on the generation of Col10a1-spe-
ciWc reporter gene mouse lines the expression of lacZ
under the control of a 4.6 kb mouse Col10a1 promoter
region was restricted to hypertrophic cartilage, indicat-
ing that the -4.6 kb mouse promoter including a 500 bp
enhancer element located at the 5-end of this region is
suYcient for tissue speciWc expression (Gebhard et al.
2004). Also in another transgenic mouse expressing
LacZ under a ¡4.0 kb proximal Col10a1 promoter
lacking the enhancer, lacZ expression was restricted to
hypertrophic cartilage, although mostly to the lower
hypertrophic zone (Zheng et al. 2003). The Col10a1
enhancer has been originally described in the human
COL10A1 gene; it was located between ¡1.9 and
¡2.4 kb by in vitro transfection studies in primary
hypertrophic chondrocytes with various reporter gene
constructs (Thomas et al. 1995; Beier et al. 1997;
Chambers et al. 2002; Riemer et al. 2002). This
enhancer is active in hypertrophic, but not in resting
zone chondrocytes. Further upstream, a silencer ele-
ment between ¡2.4 and ¡2.8 kb suppressed transcrip-
tion in non-chondrogenic cells (Beier et al. 1997). The
enhancer element is highly conserved in mammals with
78–85% sequence identity between human, bovine and
murine Col10a1 genes (Gebhard et al. 2004) and con-
tains a conserved AP-1 site which is essential for high
Fig. 5 X-gal staining of trans-
genic newborn mice of BAC-
Col10a1-lacZ-neo (a, b foun-
der line #800, F1; c–i founder 
line #1520, F1). All hypertro-
phic zones of the growth 
plates of long bones, ribs, and 
vertebrae exhibit strong LacZ 
activity. a Humerus, distal; b 
ulna, proximal; c forearm, d 
hand; e skull: C1 cervical ver-
tebrae 1 (atlas); eb ecto-occip-
ital bone; h hyoid bone; m 
mandibular condyle; MC 
Meckels cartilage; mh head of 
malleus; r head of ramus. f 
Thoracal vertebrae (left four) 
and cervical vertebrae (right 
three), view from ventral; g 
ribs; h spine, view form dorsal, 
i sternumHistochem Cell Biol (2007) 127:183–194 191
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transcription of enhancer- reporter genes in hypertro-
phic chondrocytes (Gebhard et al. 2004). In the murine
gene, the enhancer is located between ¡4.1 and
¡4.6 kb due to insertion of two virus-related sequences
in the promoter (Gebhard et al. 2004). Further cis-reg-
ulatory elements in the 4.6 kb promoter include an AP-
1 site in the proximal promoter (Harada et al. 1996)
and several runx2 bindings sites (OSE elements),
(Zheng et al. 2003).
Yet, although lacZ transgene expression in the
4.6 kb Col10a1–LacZ reporter mice was speciWc and
restricted to hypertrophic chondrocytes, not all hyper-
trophic chondrocytes in the growth plates of 18.5-day
embryos were found to be LacZ positive, and only
weak LacZ expression was observed at early embry-
onic stages before day E17 (Gebhard et al. 2004).
Furthermore, not all transgenic founders containing
the  lacZ transgene were stained with X-gal in the
growth plates, suggesting positional eVects of addi-
tional regulatory elements in the Col10a1 gene further
upstream of the enhancer or downstream of the coding
sequences. It may also indicate a high level of sensitiv-
ity to interfering activities of the genomic context of
insertion. It is possible that the ¡4.6 kb promoter
including the Wrst intron contains essential silencing
elements required for suppressing Col10a1 expression
in non-hypertrophic cartilage and in non-chondrogenic
tissues, but possibly lacks additional regulatory ele-
ments beyond the enhancer region.
In contrast, in the Col10a1-BAC transgenic lines
presented here, all hypertrophic chondrocytes showed
strong and even LacZ expression in all zones of
Fig. 6 ParaYn sections of 
transgenic newborns (a–e) 
(founder line #1520, F1) and 
E16.5 day (g) (founder line 
#1534) embryos showing 
strong and speciWc LacZ activ-
ity in all hypertrophic chon-
drocytes, e.g. in the growth 
plate of the humerus (a) (dis-
tal), elbow joint of the radius 
(b), sternebrae (c), atlas (d), 
ribs (e) and spine (f). Compar-
ison of the lacZ staining pat-
tern in the elbow joint (h 
radius) with that observed af-
ter in situ hybridization with a 
Col10a1 probe (g) in a parallel 
section illustrates that LacZ is 
expressed in the BAC trans-
genic mice only in collagen 
X expressing hypertrophic 
chondrocytes192 Histochem Cell Biol (2007) 127:183–194
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endochondral ossiWcation in embryonic and postnatal
transgenic animals. The LacZ reaction of hypertrophic
cartilage became visible already after 3–4 h of X-gal
staining, while under the control of the 4.6 kb Col10a1
promoter signiWcant LacZ activity in transgenic mice
did not become visible before 18 h staining time
(Gebhard et al. 2004).
Recently, evidence is accumulating that in many
genes further tissue-speciWc enhancers are located in
large distances from the start site of transcription. For
example, regulatory sequences were identiWed 20–
30 kb upstream of the transcription start site of the
Myo D gene (Goldhamer et al. 1992) or the Ubx gene
in Drosophila (Irvine et al. 1991), up to 270 kb down-
stream in the mouse BMP5 gene (DiLeone et al. 2000)
or between 290K kb upstream and 450 kb downstream
of the Sox9 gene (Bagheri-Fam et al. 2006). Thus we
cannot exclude that additional tissue-speciWc regula-
tory elements may be present in the Col10a1 gene,
either upstream in the region between ¡170 kb and the
enhancer at ¡4.6 kb, or downstream of the 3-end of
the Col10a1 gene. The BAC transgenic reporter lines
established here would facilitate the identiWcation of
such elements by generating further mutants using the
homologous recombination technique (DiLeone et al.
2000).
Reasons for the high reporter gene expression levels
in the BAC-Col10a1-lacZ-neo reporter lines in com-
parison to the 4.6 kb Col10a1-lacZ mice are for one
part the high copy number of BAC transgenes, and for
the other part the favorable und undisturbed condi-
tions for transgene expression in the BAC environ-
ment. The X-gal staining intensity in founder line
#1520 harboring seven BAC transgene copies was
clearly higher than that of founder line #986 harboring
only three BAC copies. But in addition, the use of tar-
geted BAC recombination permits the expression of
genes in their genomic context, containing most rele-
vant regulatory regions in the correct orientation and
distance, in contrast to conventional transgenic mice
generated by injection of short reporter genes. This
strategy is less sensitive to unpredictable inXuences by
regions surrounding the random integration site (Mort-
lock et al. 2003). The expression pattern of LacZ, how-
ever, was very similar in all seven BAC lines analyzed
so far, apparently independent of the integration sites
and the copy number of the BAC transgene.
Most E14.5- to E16.5-day BAC-Col10a1-lacZ-neo
transgenic embryos showed some X-gal staining in hair
follicles of the forehead and snout, and of the epider-
mis of the tail, legs and shoulder, which disappears
after birth. In the X-gal positive spots, staining was
restricted to the basal layer of keratinocytes. Since
these cells do not express type X collagen, the eVect
may be due to endogenous galactosidase activity, or a
result of LacZ activation by other, Col10a1-unrelated
regulatory elements located in the BAC clone.
In addition to Col10a1, the BAC clone RP23-192A7
contains coding regions of three additional genes
Tspyl-1, Tspyl1-4 and Nt5dc1. Whether these genes are
expressed under their endogenous promoters in the
BAC transgenic mice is currently investigated. If they
are expressed, they could aVect the phenotype of the
established transgenic mouse lines, but no phenotypic
alteration in skeletal elements nor in other tissues have
been observed in transgenic embryos, newborn or
adults as compared to wildtype littermates.
The high intensity of X-gal staining under the con-
trol of the BAC-Col10a1 promoter allowed the visuali-
zation of discrete zones of Col10a1 expression in
hypertrophic cartilage of anatomical structures not
investigated so far in such detail and completeness, for
example the skull or the inner and outer aspects of the
thoracal and cervical vertebrae. The data presented in
this study illustrate the superior potential of reporter
gene expression analysis in combination with BAC rec-
ombineering technique as compared to conventional in
situ hybridization analysis.
The robust and speciWc expression of the lacZ
reporter gene under the control of BAC-Col10a1 envi-
ronment furthermore shows that the placH+Col10a1-
lacZ-frt-neo-frt targeting vector may be an extremely
versatile vector for the targeted overexpression of
other genes in hypertrophic chondrocytes of growth
plates with high eYciency and speciWcity. Thus, the
Col10a1-based BAC vector may be a useful tool to
analyze the role of eVector genes in skeletal develop-
ment, endochondral ossiWcation, and fracture callus
formation.
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